These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25613637)

  • 1. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin.
    Yiannakopoulou E
    Pharmacology; 2015; 95(1-2):65-9. PubMed ID: 25613637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmetic complications: rare and serious events following botulinum toxin and soft tissue filler administration.
    Sorensen EP; Urman C
    J Drugs Dermatol; 2015 May; 14(5):486-91. PubMed ID: 25942667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic botulism in a child with spastic quadriparesis.
    Partikian A; Mitchell WG
    J Child Neurol; 2007 Oct; 22(10):1235-7. PubMed ID: 17940253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin: pharmacology and clinical developments: a literature review.
    Hackett R; Kam PC
    Med Chem; 2007 Jul; 3(4):333-45. PubMed ID: 17627570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of botulinum toxin.
    Huang W; Foster JA; Rogachefsky AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):249-59. PubMed ID: 10906647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies.
    Giordano CN; Matarasso SL; Ozog DM
    J Am Acad Dermatol; 2017 Jun; 76(6):1027-1042. PubMed ID: 28522039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: a dreaded toxin for use in human being.
    Ghosh B; Das SK
    J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrotising fasciitis as a complication of botulinum toxin injection.
    Latimer PR; Hodgkins PR; Vakalis AN; Butler RE; Evans AR; Zaki GA
    Eye (Lond); 1998; 12 ( Pt 1)():51-3. PubMed ID: 9614517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hemifacial spasm with botulinum toxin.
    Yoshimura DM; Aminoff MJ; Tami TA; Scott AB
    Muscle Nerve; 1992 Sep; 15(9):1045-9. PubMed ID: 1518513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin and pregnancy-a cautionary tale.
    Li Yim JF; Weir CR
    Strabismus; 2010 Jun; 18(2):65-6. PubMed ID: 20521881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pearls and pitfalls in the therapeutic use of botulinum toxin.
    Smith AG
    Semin Neurol; 2004 Jun; 24(2):165-74. PubMed ID: 15257513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible adverse effects of intramuscular botulinum toxin injections and their management.
    Bakheit AM
    Curr Drug Saf; 2006 Aug; 1(3):271-9. PubMed ID: 18690938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.
    Chen JJ; Dashtipour K
    Pharmacotherapy; 2013 Mar; 33(3):304-18. PubMed ID: 23400888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granuloma annulare after Botulonium toxin A injection: A rare association.
    Balighi K; Kamyab K; Azizpour A
    J Cosmet Dermatol; 2020 Oct; 19(10):2549-2551. PubMed ID: 32030860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
    Ramirez-Castaneda J; Jankovic J
    Toxicon; 2014 Nov; 90():344-8. PubMed ID: 25130293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.